Projects per year
Personal profile
Personal profile
Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.
Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.
Research Area Keywords
- Cancer
- Clinical Translation & Trials
- Molecular Medicine
Fingerprint
Dive into the research topics where S. Ravi Pingali is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Darcourt, J., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial
-
Phase II_PevonedistatVenetoclaxAzacitidine_AML_Pevonedistat-2002Takeda A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Darcourt, J., Petkova, J., Pingali, S. R. & Rice, L.
4/30/21 → …
Project: Clinical Trial
-
CHEST CYTOSTORM study
Gotur, D. B., Chang, J. C., Ensor, Jr., J. E., Pingali, S. R. & Rosato, R. R.
3/8/21 → …
Project: Clinical Trial
-
A Phase 2, Multicenter, Single-arm Study of Retreatment With Brentuximab Vedotin in Subjects With Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or CD30-expressing Peripheral T Cell Lymphoma (PTCL)
Pingali, S. R., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Petkova, J., Randhawa, J., Rice, L. & Singh, M.
7/8/20 → …
Project: Clinical Trial
-
A Phase 2 Open-label Study of Brentuximab Vedotin in Front-line Therapy of Hodgkin Lymphoma (HL) an dCD30-expressing Peripheral T-cell Lymphoma (PTCL) in Older Patients or Patients With Significant Comorbidities Ineligible for Standard Chemotherapy
Pingali, S. R., Darcourt, J., Petkova, J. & Rice, L.
7/8/20 → …
Project: Clinical Trial
Research output
-
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
Youssef, J. G., Zahiruddin, F., Youssef, G., Padmanabhan, S., Ensor, J., Pingali, S. R., Zu, Y., Sahay, S. & Iyer, S. P., Mar 2021, In: Annals of Hematology. 100, 3, p. 667-673 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients
Sirimaturos, M., Gotur, D. B., Patel, S. J., Dreucean, D., Jakowenko, N., Cooper, M. H., Brahmbhatt, N., Graviss, E. A., Nguyen, D. T., Pingali, S. R., Lin, J. & Musick, W. L., Oct 2020, In: Critical care explorations. 2, 10, p. e0232Research output: Contribution to journal › Article › peer-review
-
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
Wang, Q., Zhao, D., Xian, M., Wang, Z., Bi, E., Su, P., Qian, J., Ma, X., Yang, M., Liu, L., Zu, Y., Pingali, S. R., Chen, K., Cai, Z. & Yi, Q., Nov 26 2020, In: Blood. 136, 22, p. 2557-2573 17 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors
Anand, K., Sahu, G., Burns, E., Ensor, A., Ensor, J., Pingali, S. R., Subbiah, V. & Iyer, S. P., Aug 18 2020, In: ESMO Open. 5, 4, e000866.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review
Anand, K., Burns, E. A., Ensor, J., Rice, L. & Pingali, S. R., Jan 2020, In: Clinical Lymphoma, Myeloma and Leukemia. 20, 1, p. 18-23 6 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations